Direct activation of RIP3/MLKL-dependent necrosis by herpes simplex virus 1 (HSV-1) protein ICP6 triggers host antiviral defense Journal Article


Authors: Wang, X.; Li, Y.; Liu, S.; Yu, X.; Li, L.; Shi, C.; He, W.; Li, J.; Xu, L.; Hu, Z.; Yu, L.; Yang, Z.; Chen, Q.; Ge, L.; Zhang, Z.; Zhou, B.; Jiang, X.; Chen, S.; He, S.
Article Title: Direct activation of RIP3/MLKL-dependent necrosis by herpes simplex virus 1 (HSV-1) protein ICP6 triggers host antiviral defense
Abstract: The receptor-interacting kinase-3 (RIP3) and its downstream substrate mixed lineage kinase domain-like protein (MLKL) have emerged as the key cellular components in programmed necrotic cell death. Receptors for the cytokines of tumor necrosis factor (TNF) family and Toll-like receptors (TLR) 3 and 4 are able to activate RIP3 through receptor-interacting kinase-1 and Toll/IL-1 receptor domain-containing adapter inducing IFN-β, respectively. This form of cell death has been implicated in the host-defense system. However, the molecular mechanisms that drive the activation of RIP3 by a variety of pathogens, other than the above-mentioned receptors, are largely unknown. Here, we report that human herpes simplex virus 1 (HSV-1) infection triggers RIP3-dependent necrosis. This process requires MLKL but is independent of TNF receptor, TLR3, cylindromatosis, and host RIP homotypic interaction motif-containing protein DNA-dependent activator of IFN regulatory factor. After HSV-1 infection, the viral ribonucleotide reductase large subunit (ICP6) interacts with RIP3. The formation of the ICP6-RIP3 complex requires the RHIM domains of both proteins. An HSV-1 ICP6 deletion mutant failed to cause effective necrosis of HSV-1-infected cells. Furthermore, ectopic expression of ICP6, but not RHIM mutant ICP6, directly activated RIP3/MLKL-mediated necrosis. Mice lacking RIP3 exhibited severely impaired control of HSV-1 replication and pathogenesis. Therefore, this study reveals a previously uncharacterized host antipathogen mechanism.
Keywords: controlled study; protein expression; unclassified drug; nonhuman; protein domain; animal cell; mouse; animal tissue; cell death; complex formation; animal experiment; animal model; herpes simplex; immunoglobulin enhancer binding protein; virus replication; host resistance; herpes simplex virus 1; phosphotransferase; antiviral activity; deletion mutant; virus mutant; ribonucleotide reductase; virus entry; toll like receptor 3; male; article; hsv-1; icp6; mlkl; programmed necrosis; rip3; receptor interacting kinase 3
Journal Title: Proceedings of the National Academy of Sciences of the United States of America
Volume: 111
Issue: 43
ISSN: 0027-8424
Publisher: National Academy of Sciences  
Date Published: 2014-10-28
Start Page: 15438
End Page: 15443
Language: English
DOI: 10.1073/pnas.1412767111
PROVIDER: scopus
PMCID: PMC4217423
PUBMED: 25316792
DOI/URL:
Notes: Export Date: 1 December 2014 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Xuejun Jiang
    121 Jiang